Primary Graft Dysfunction clinical trials
The registry lists 21 studies for Primary Graft Dysfunction across 9 countries. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-07-22.
Status
- Status unknown
- 6
- Completed
- 6
- Recruiting
- 4
- Terminated
- 3
- Active, not recruiting
- 1
- Withdrawn
- 1
Phase
- Phase 2
- 6
- Phase 1
- 1
- Phase 3
- 1
Where
- United States
- 5
- Canada
- 4
- Italy
- 3
- Belgium
- 2
- France
- 2
- Austria
- 2
Who runs them
University of Pennsylvania (2) · University Health Network, Toronto (2) · University Hospital, Strasbourg, France (2) · University Hospital of Mont-Godinne (2) · Policlinico Hospital (2) · University Hospital, Motol (1) · Lund University Hospital (1) · Apeptico Forschung und Entwicklung GmbH (1)
Studies
Recruiting first, then most recently updated. Showing 21 of 21 — search for more.
- Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung TransplantationRecruitingNCT005523571 country
- Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft DysfunctionRecruitingNCT07230886Not applicable1 country
- This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft DysfunctionRecruitingNCT06853223Phase 21 country
- Exhaled Breath Particles in Lung TransplantationRecruitingNCT053751491 country
- Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung TransplantationActive, not recruitingNCT004578471 country
- Point-of-care Management of Coagulopathy in Lung TransplantationTerminatedNCT035989071 country
- Identifying Optimal PEEP After Lung TransplantationCompletedNCT05691205Not applicable1 country
- Repertaxin in Prevention of Primary Graft Dysfunction After Lung TransplantationCompletedNCT00224406Phase 22 countries
- CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung TransplantationTerminatedNCT045583331 country
- Primary Graft Dysfunction, Pronation, Bilateral Lung TransplantsCompletedNCT06159933Not applicable1 country
- Perioperative Vitamin C Lung TransplantWithdrawnNCT04505878Phase 2
- Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung TransplantationCompletedNCT02095626Phase 21 country
- Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft DysfunctionTerminatedNCT01715883Phase 21 country
- Measurement of Extravascular Lung Water to Detect and Predict Primary Graft Dysfunction Following Lung TransplantStatus unknownNCT016052141 country
- Heart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg ExperienceStatus unknownNCT031568941 country
- Primary Graft Dysfunction Score in Lung TransplantationStatus unknownNCT032764032 countries
- Lung PGD Biomarkers in Organ DonorsStatus unknownNCT03089489
- Pneumoproteins Expression in the Organ DonorCompletedNCT020320691 country
- Ex-Vivo Lung Perfusion to Increase the Number of Organs for TransplantationCompletedNCT01967953Phase 11 country
- Quantifying Physical and Biochemical Factors That Contribute to Primary Graft Dysfunction After Lung TransplantationStatus unknownNCT011518261 country
- The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot StudyStatus unknownNCT00506532Phase 2/31 country